BioClinica, Inc.. Technologies Earnings Conference Call (Q2 2009)  Today's Calls

Visit the TF Network Sites· Corporate IR Center · Institutional Investor Center · Individual Investor Center Download Plug-In Real Player 8 Basic Windows Media Player Other Conference Calls Other Aug 5 Calls Today's Calls

Call Details BioClinica, Inc.. Technologies Earnings Conference Call (Q2 2009) Wed, Aug 5, 2009, 8:30 am Eastern Listen to the archived event audio About BioClinica, Inc. (NasdaqGM:BIOC) Other Calls  BioClinica, Inc. operates as a global provider of clinical trials services, helping to support drug and product development efforts through various phases of the clinical trial process. BioClinica, created from the acquisition of Phoenix Data Systems, Inc. by Bio-Imaging Technologies, Inc., offers medical image management and electronic data capture to companies in the life sciences industry. The company also provides solutions that combine these core services to maximize efficiency and manageability throughout the clinical development process. BioClinica, with approximately 2,000 successful trials, helps in bringing various drugs from early phase development through final approval. It operates two FDA-compliant core labs in the United States and Europe. The company was formerly known as Bio-Imaging Technologies, Inc. and changed its name to BioClinica, Inc. on July 8, 2009. BioClinica was founded in 1987 and is based in Newtown, Pennsylvania with business offices in the United States, France, Germany, the United Kingdom, and the Netherlands. More Info: Quote | Financials | Analyst Ratings